CSF1R and atherosclerosis: However, we have reason to believe that the overexpression of CSF1R is critical to the development of atherosclerosis, and targeting CSF1R as a therapeutic target may reduce the pathologic cascade of pro-atherosclerotic-related factors in patients, and provide some protection against disease progression in patients with atherosclerosis.